The measurement of the QT interval

Current Cardiology Reviews

Volumn 10, Issue 3, 2014, Pages 287-294

  Postema, Pieter G ^a   Wilde, Arthur A M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Arrhythmias; Long QT syndrome; QT interval; Sudden death

Indexed keywords

LEAD;

ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR SYSTEM EXAMINATION; ECG ABNORMALITY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; GAIN OF FUNCTION MUTATION; HEART ATRIUM FIBRILLATION; HEART RATE; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; LOSS OF FUNCTION MUTATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; QT VARIABILITY INDEX; SHORT QT SYNDROME; SINUS ARRHYTHMIA; T WAVE; TACHYCARDIA; U WAVE; HEART ARRHYTHMIA; PHYSIOLOGY; REVIEW; SUDDEN CARDIAC DEATH;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; LONG QT SYNDROME;

EID: 84904259160     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/1573403X10666140514103612     Document Type: Article

References (60)

1. [1] Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital long-QT syndrome. Circulation 2007; 115: 2613-20.
2. [2] Garg A, Lehmann MH. Prolonged QT interval diagnosis suppression by a widely used computerized ECG analysis system. Circ Arrhythm Electrophysiol 2013; 6: 76-83.
3. [3] Einthoven W. Ueber die Form des menschlichen Electrocardiogramms. Pflugers Arch Gesamte Physiol 1895; 60: 101-23.
4. [4] Einthoven W. Le telecardiogramme. Arch Int Physiol 1906; 4: 132-64.
5. [5] Einthoven W. The different forms of the human electrocardiogram and their signification. Lancet 1912; 179: 853-61.
6. [6] Lewis T, Gilder MDD. The human electrocardiogram: a preliminary investigation of young male adults, to form a basis for pathological study. Philos Trans R Soc Lond B Biol Sci 1912; 202: 351-76.
7. [7] Wolff L. Electrocardiography. Fundamentals and clinical application. Philadelphia: W.B. Saunders company 1950.
8. [8] Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957; 54: 59-68.
9. [9] Jervell A, Thingstad R, Endsjö TO. The surdo-cardiac syndrome: three new cases of congenital deafness with syncopal attacks and Q-T prolongation in the electrocardiogram. Am Heart J 1966; 72: 582-93.
10. [10] Postema PG, Van den Berg MP, Van Tintelen JP, et al. Founder mutations in the Netherlands. SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best described characterised families worldwide. Neth Heart J 2009; 17: 422-8.
11. [11] Romano C, Gemme G, Pongiglione R. Rare cardiac arrhythmias of the pediatric age. II. Syncopal attacks due to paroxysmal ventricular fibrillation [Italian]. Clin Pediatr (Bologna) 1963; 45: 656-683.
12. [12] Ward OC. A new familial cardiac syndrome in children. J Ir Med Assoc 1964; 54: 103-6.
13. [13] Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991; 252: 704-6.
14. [14] Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000; 102: 1178-85.
15. [15] Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT interval: a new clinical syndrome? Cardiology 2000; 94: 99-102.
16. [16] Villafañe J, Atallah J, Gollob MH, et al. Long-term follow-up of a pediatric cohort with short QT syndrome. J Am Coll Cardiol 2013; 61: 1183-91.
17. [17] Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004; 109: 30-5.
18. [18] Bellocq C, Van Ginneken AC, Bezzina CR, et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004; 109: 2394-7.
19. [19] Priori SG, Pandit SV, Rivolta I, et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005; 96: 800-7.
20. [20] Woosley RL, Cossman J. Drug development and the FDA’s Critical Path Initiative. Clin Pharmacol Ther 2007; 81: 129-33.
21. [21] Coronel R, De Bakker JM, Wilms-Schopman FJ, et al. Monophasic action potentials and activation recovery intervals as measures of ventricular action potential duration: experimental evidence to resolve some controversies. Heart Rhythm 2006; 3: 1043-50.
22. [22] Opthof T, Coronel R, Janse MJ. Is there a significant transmural gradient in repolarization time in the intact heart?: Repolarization gradients in the intact heart. Circ Arrhythm Electrophysiol 2009; 2: 89-96.
23. [23] Patel C, Burke JF, Patel H, et al. Is there a significant transmural gradient in repolarization time in the intact heart? Cellular basis of the T wave: a century of controversy. Circ Arrhythm Electrophysiol 2009; 2: 80-8.
24. [24] Janse MJ, Coronel R, Opthof T. Counterpoint: M cells do not have a functional role in the ventricular myocardium of the intact heart. Heart Rhythm 2011; 8: 934-7.
25. [25] Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952; 6: 378-88.
26. [26] Garson A. How to measure the QT interval--what is normal? Am J Cardiol 1993; 72: 14B-6B. [27] Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920; 7: 353-70.
27. [28] Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993; 72: 23B-5B.
28. Moennig G, Schulze-Bahr E, Wedekind H, et al. Clinical value of electrocardiographic parameters in genotyped individuals with familial long QT syndrome. Pacing Clin. Electrophysiol 2001; 24: 406-15.
29. [30] Garson A Jr, Dick M 2nd, Fournier A, et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993; 87: 1866-72.
30. [31] Postema PG, Ritsema van Eck HJ, Opthof T, et al. IK1 modulates the U-wave: insights in a 100 year old enigma. Heart Rhythm 2009; 6: 393-400.
31. [32] Zhang L, Benson DW, Tristani-Firouzi M, et al. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 2005; 111: 2720-6.
32. [33] Viskin S, Rosovski U, Sands AJ, et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm 2005; 2: 569-74.
33. [34] Postema PG, De Jong JS, Van der Bilt IA, Wilde AA. Accurate electrocardiographic assessment of the QT-interval: teach the tangent. Heart Rhythm 2008; 5: 1015-8.
34. [35] Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is “normal”. J Cardiovasc. Electrophysiol 2006; 17: 333-6.
35. [36] Panicker GK, Karnad DR, Natekar M, Kothari S, Narula D, Lokhandwala Y. Intra-and interreader variability in QT interval measurement by tangent and threshold methods in a central electrocardiogram laboratory. J Electrocardiol 2009; 42: 348-52.
36. [37] Funck-Brentano C, Jaillon P. Rate-corrected QT interval: techniques and limitations. Am J Cardiol 1993; 72: 17B-22B.
37. Fridericia LS. Die Systolendauer im Elektrokardiogramm bei normalen Menchen und bei Herzkranken. Acta Med Scand 1920; 53: 469-86.
38. Luo S, Michler K, Johnston P, Macfarlane PW. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 2004; 37 Suppl: 81-90.
39. [40] Barsheshet A, Peterson DR, Moss AJ, et al. Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome. Heart Rhythm 2011; 8: 1207-13.
40. [41] Kirchhof P, Franz MR, Bardai A, Wilde AM. Giant T-U waves precede Torsades de Pointes in Long QT syndrome. A systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. J Am Coll Cardiol 2009; 54: 143-9.
41. [42] Viskin S. The QT interval: too long, too short or just right. Heart Rhythm 2009; 6: 711-5.
42. [43] Crotti L, Monti MC, Insolia R, et al. NOS1AP is a genetic modifier of the Long-QT syndrome. Circulation 2009; 120: 1657-63.
43. [44] Goldenberg I, Horr S, Moss AJ, et al. Risk for life-threatening cardiac events in patients with genotype-confirmed Long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol 2010; 57: 51-9.
44. [45] Hofman N, Wilde AA, Kaab S, et al. Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J 2007; 28: 575-80.
45. [46] Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003; 348: 1866-74.
46. [47] Tomás M, Napolitano C, De Giuli L, et al. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J Am Coll Cardiol 2010; 55: 2745-52.
47. [48] Viskin S, Postema PG, Bhuiyan ZA, et al. The response of the QTinterval to the brief tachycardia provoked by standing. A bedside test for diagnosing Long-QT syndrome. J Am Coll Cardiol 2010; 55: 1955-61.
48. [49] Adler A, Van der Werf C, Postema PG, et al. The phenomenon of “QT stunning”: The abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. Heart Rhythm 2012; 9: 901-8.
49. [50] Sy RW, Van der Werf C, Chattha IS, et al. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation 2011; 124: 2187-94.
50. [51] Berger WR, Gow RM, Kamberi S, Cheung M, Smith KR, Davis AM. The QT and corrected QT interval in recovery after exercise in children. Circ Arrhythm Electrophysiol 2011; 4: 448-55.
51. [52] Schwartz PJ, Spazzolini C, Priori SG, et al. Who are the Long-QT syndrome patients who receive an implantable cardioverterdefibrillator and what happens to them? Data from the European Long-QT syndrome implantable cardioverter-defibrillator (LQTS ICD) registry. Circulation 2010; 122: 1272-82.
52. Postema PG, Neville J, De Jong JS, Romero K, Wilde AA, Woosley RL. Safe drug use in Long QT syndrome and Brugada syndrome: www.QTdrugs.org and www.BrugadaDrugs.org. Europace 2013; 15: 1042-9.
53. [54] Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997; 96: 1557-65.
54. [55] Bilchick K, Viitasalo M, Oikarinen L, Fetics B, Tomaselli G, Swan H, Laitinen PJ, Vaananen H, Kontula K, Berger RD. Temporal repolarization lability differences among genotyped patients with the long QT syndrome. Am J Cardiol 2004; 94: 1312-6.
55. [56] Nemec J, Buncova M, Shusterman V, Winter B, Shen WK, Ackerman MJ. QT interval variability and adaptation to heart rate changes in patients with long QT syndrome. Pacing Clin Electrophysiol 2009; 32: 72-81.
56. [57] Malik M. Beat-to-beat QT variability and cardiac autonomic regulation. Am. J. Physiol. Heart Circ Physiol 2008; 295: H923-5.
57. [58] Thomsen MB, Verduyn SC, Stengl M, et al. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Circulation 2004; 110: 2453-9.
58. [59] Hinterseer M, Thomsen MB, Beckmann BM, et al. Beat-to-beat variability of QT intervals is increased in patients with druginduced long-QT syndrome: a case control pilot study. Eur Heart J 2008; 29: 185-90.
59. [60] Hinterseer M, Beckmann BM, Thomsen MB, et al. Relation of increased short-term variability of QT interval to congenital long-QT syndrome. Am J Cardiol 2009; 103: 1244-8.
60. [61] Mathias A, Moss AJ, Lopes CM, et al. Prognostic implications of mutation specific QTc standard deviation in congenital Long QT syndrome. Heart Rhythm 2013; 10: 720-5.